XCELLA BIOSCIENCES

XCella Biosciences is an antibody discovery company that offers a platform that can screen single B cells. It develops therapeutics to transform patient outcomes with protein engineering and disruptive technology. xCella's xPloration is an integrated hardware and software platform that enables high dimensional measurement and analysis of genotype, phenotype, and cellular functions at the single-cell level, millions of cells at a time. The company was founded in 2015 and based in Menlo Park, California.